Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.820
+0.010 (0.55%)
At close: Sep 5, 2025, 4:00 PM
1.900
+0.080 (4.40%)
After-hours: Sep 5, 2025, 7:41 PM EDT

Company Description

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.

It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025.

Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics logo
CountryUnited States
Founded2007
IndustryBiotechnology
SectorHealthcare
Employees40
CEODavid Lennon

Contact Details

Address:
2 Headquarters Plaza, East Building
Morristown, New Jersey 07960
United States
Phone551 321 2234
Websiteir.whitehawktx.com

Stock Details

Ticker SymbolWHWK
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001422142
CUSIP Number00032Q104
ISIN NumberUS00032Q1040
Employer ID61-1547850
SIC Code2834

Key Executives

NamePosition
Dr. David J. Lennon Ph.D.President, Chief Executive Officer and Director
Dr. Neil P. Desai Ph.D.Founder and Director
Scott M. Giacobello CPAChief Financial Officer, Treasurer, Investor Relations and Corporate Communications
Bryan BallChief Technical Operations Officer
Dr. David Dornan Ph.D.Chief Scientific Officer
Stephen M. Rodin J.D.Senior Vice President of Legal and General Counsel

Latest SEC Filings

DateTypeTitle
Aug 25, 2025SCHEDULE 13GFiling
Aug 7, 202510-QQuarterly Report
Aug 7, 20258-KCurrent Report
Jun 13, 20258-KCurrent Report
May 22, 2025UPLOADFiling
May 15, 2025SCHEDULE 13GFiling
May 15, 2025SCHEDULE 13G/AFiling
May 8, 202510-QQuarterly Report
May 8, 20258-KCurrent Report
May 7, 2025UPLOADFiling